down arrow

Gland Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Net Sales
2,807.54
2,582.12
1,901.30
2,234.37
1,715.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,807.54
2,582.12
1,901.30
2,234.37
1,715.71
Raw Material Cost
947.53
983.45
845.18
979.33
845.90
Purchase of Finished goods
9.24
9.93
8.54
12.14
9.22
(Increase) / Decrease In Stocks
182.95
-18.91
39.80
69.04
-161.66
Employee Cost
685.34
559.96
199.30
162.89
150.90
Power Cost
91.89
108.07
66.12
45.79
35.99
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
329.14
321.58
175.59
152.29
125.05
Total Expenditure (Excl Depreciation)
2,246.09
1,964.08
1,334.53
1,421.48
1,005.39
Operating Profit (PBDIT) excl Other Income
561.45
618.04
566.77
812.89
710.32
Other Income
111.09
90.70
140.02
113.04
52.43
Operating Profit (PBDIT)
672.54
708.74
706.79
925.93
762.75
Interest
11.73
10.96
2.62
2.03
1.23
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
660.81
697.78
704.17
923.90
761.52
Depreciation
185.79
146.62
71.58
51.39
48.89
Profit Before Tax
475.02
551.15
632.58
872.51
712.63
Tax
167.73
162.97
162.17
219.77
180.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
307.29
388.18
470.41
652.73
532.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
307.29
388.18
470.41
652.73
532.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
307.29
388.18
470.41
652.73
532.45
Equity Capital
16.48
16.47
16.47
16.42
15.50
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
6,579.18
0.00
Earnings per share (EPS)
18.65
23.57
28.56
39.75
34.35
Diluted Earnings per share
18.65
23.57
28.57
39.78
34.36
Operating Profit Margin (Excl OI)
20.0%
23.94%
29.81%
36.38%
41.4%
Gross Profit Margin
23.54%
27.02%
37.04%
41.35%
44.39%
PAT Margin
10.95%
15.03%
24.74%
29.21%
31.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 8.73% vs 35.81% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is -20.84% vs -17.48% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is -9.16% vs 9.05% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 7.03% vs 318.32% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Gland Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,807.54
5,969.93
-3,162.39
-52.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,807.54
5,969.93
-3,162.39
-52.97%
Raw Material Cost
947.53
934.97
12.56
1.34%
Purchase of Finished goods
9.24
857.27
-848.03
-98.92%
(Increase) / Decrease In Stocks
182.95
-104.82
287.77
274.54%
Employee Cost
685.34
1,280.21
-594.87
-46.47%
Power Cost
91.89
0.00
91.89
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
329.14
1,470.50
-1,141.36
-77.62%
Total Expenditure (Excl Depreciation)
2,246.09
4,438.13
-2,192.04
-49.39%
Operating Profit (PBDIT) excl Other Income
561.45
1,531.80
-970.35
-63.35%
Other Income
111.09
210.03
-98.94
-47.11%
Operating Profit (PBDIT)
672.54
1,741.83
-1,069.29
-61.39%
Interest
11.73
18.01
-6.28
-34.87%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
660.81
1,723.82
-1,063.01
-61.67%
Depreciation
185.79
213.36
-27.57
-12.92%
Profit Before Tax
475.02
1,510.46
-1,035.44
-68.55%
Tax
167.73
314.99
-147.26
-46.75%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
307.29
1,195.47
-888.18
-74.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
307.29
1,195.47
-888.18
-74.30%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
307.29
1,189.96
-882.67
-74.18%
Equity Capital
16.48
40.06
-23.58
-58.86%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
18.65
29.70
-11.05
-37.21%
Diluted Earnings per share
18.65
29.65
-11.00
-37.10%
Operating Profit Margin (Excl OI)
20.00%
25.66%
0.00
-5.66%
Gross Profit Margin
23.54%
28.88%
0.00
-5.34%
PAT Margin
10.95%
20.13%
0.00
-9.18%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 2,807.54 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 8.73% vs 35.81% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 307.29 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -20.84% vs -17.48% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 561.45 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -9.16% vs 9.05% in Sep 2023

Half Yearly - Interest
Interest 11.73 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 7.03% vs 318.32% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.00%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023